Reproductive Immunology

Reproductive Immunology is the study of how the immune system affects implantation, pregnancy loss, and fertility. Research in this field has mapped several immune pathways that matter for pregnancy. Antiphospholipid syndrome (APS) is the clearest example. In APS, the body makes antibodies that raise the risk of blood clots, including clots in the placenta. APS is a treatable cause of recurrent pregnancy loss. ESHRE, the European fertility society, has a guideline on recurrent loss. It recommends testing for these antibodies after two losses. Some women meet the lab criteria for APS and have had three or more losses. For them, it suggests blood-thinning treatment.¹² APS stands on firm ground because its lab criteria are clear. A diagnosis needs a positive antibody test. A repeat test weeks later must confirm it. Uterine natural killer cells are immune cells in the endometrium, the lining of the uterus. High activity in these cells is a proposed cause of implantation failure with no other known cause. RRM clinicians still consider this question. The same ESHRE guideline finds the evidence too limited to recommend routine testing. That guideline covers recurrent loss, not implantation failure. A 2022 review pooled the published studies. Women with recurrent miscarriage had higher levels of these cells in the endometrium. So did women with repeated implantation failure. The authors said a standard reference range must come first. Only then can the test guide care.³ The gap is a missing measurement standard, not a lack of signal. Chronic endometritis, a long-term inflammation of the endometrium, disrupts that lining. It is linked with repeated implantation failure and pregnancy loss.⁴ The uterine microbiome, the community of bacteria in the uterus, is a related area of study. An imbalance there tracks with implantation outcomes even when the structure of the uterus is normal.⁵ RRM clinicians may add an immune workup when the clinical picture points to an immune cause. This is most common for couples with recurrent pregnancy loss or thrombophilia, a tendency to form blood clots.